Breaking News Instant updates and real-time market news.

PRQR

ProQR Therapeutics

$6.24

-0.06 (-0.95%)

16:17
10/15/19
10/15
16:17
10/15/19
16:17

ProQR Therapeutics announces $50M offering of ordinary shares

ProQR Therapeutics N.V. announced that it intends to offer and sell $50M of its ordinary shares in an underwritten public offering. ProQR intends to use the net proceeds from the offering to fund ongoing research and development activities and for working capital and other general corporate purposes. Citigroup and Evercore ISI are acting as joint bookrunners for the offering.

PRQR ProQR Therapeutics
$6.24

-0.06 (-0.95%)

02/20/19
SBSH
02/20/19
NO CHANGE
SBSH
Buy
Citi opens 90-day catalyst watch on ProQR Therapeutics
Citi analyst Yigal Nochomovitz opened a 90-day catalyst watch on ProQR Therapeutics in anticipation of the interim Phase 1/2 Wings data for QR-313 in dystrophic epidermolysis bullosa. On positive data, or evidence of exon skipping in biopsies and evidence of skin lesion/blister resolution, the analyst sees the stock up 15%-25%. On negative data, he sees downside of 10%-15%. Nochomovitz has a Buy rating on ProQR Therapeutics.
03/27/19
CANT
03/27/19
NO CHANGE
Target $40
CANT
Overweight
ProQR Therapeutics spin-out 'smart, but not surprising,' says Cantor Fitzgerald
Cantor Fitzgerald analyst Eliana Merle thinks ProQR Therapeutics' spin-out of its dystrophic epidermolysis bullosa program is a "smart, but not surprising," strategic move. Given that the company has communicated it wants to focus on its ophthalmology programs, investors are unlikely to find this announcement about the skin program spin-out surprising, Merle tells investors in a research note. The analyst keeps an Overweight rating on ProQR Therapeutics with a $40 price target.
10/09/19
CANT
10/09/19
NO CHANGE
Target $40
CANT
Overweight
ProQR shares could more than double on tomorrow's data, says Cantor Fitzgerald
Cantor Fitzgerald analyst Eliana Merle reiterates an Overweight rating on ProQR Therapeutics with a $40 price target ahead of tomorrow's data update on lead program QR-110, which is in development for LCA10, a rare genetic form of blindness. Investors view ProQR and QR-110 as a "show-me story," but these data could lift a "significant overhang" around platform safety and serve as a "key piece of clinical de-risking" for QR-110's Phase 2/3 trial under way, Merle tells investors in a research note partially titled "A double by this time tomorrow?". The analyst thinks the stock could trade up 50%-150% tomorrow versus downside to its cash position of ~$2 per share, or ~65%.
10/10/19
SBSH
10/10/19
NO CHANGE
Target $40
SBSH
Buy
ProQR Therapeutics price target raised to $40 from $34 at Citi
Citi analyst Yigal Nochomovitz raised his price target on ProQR Therapeutics to $40 from $34, stating that he disagree's with the market's initial take on the company's updated data on sepofarsen. Given his view that the 12-month data validate the treatment benefits observed at 3 months, Nochomovitz increased his odds on the success for sepofarsen in patients with Leber's congenital amaurosis 10 to 70% from 50% and keeps his Buy rating on the stock. In afternoon trading, ProQR shares are down 26c, or 4%, to $5.95.

TODAY'S FREE FLY STORIES

PYPL

PayPal

$102.07

-0.61 (-0.59%)

, FB

Facebook

$194.47

4.9 (2.58%)

18:22
11/12/19
11/12
18:22
11/12/19
18:22
Hot Stocks
PayPal CFO: We are a better company, stronger workforce with veterans »

In an interview on…

PYPL

PayPal

$102.07

-0.61 (-0.59%)

FB

Facebook

$194.47

4.9 (2.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 10

    Dec

EADSY

Airbus

$0.00

(0.00%)

, AFLYY

Air France-KLM

$0.00

(0.00%)

18:22
11/12/19
11/12
18:22
11/12/19
18:22
Periodicals
Airbus says could stretch A220 jet to carry more passengers, Reuters says »

Philippe Balducchi, head…

EADSY

Airbus

$0.00

(0.00%)

AFLYY

Air France-KLM

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CCNE

CNB Financial

$33.10

-0.23 (-0.69%)

18:21
11/12/19
11/12
18:21
11/12/19
18:21
Syndicate
CNB Financial offering up to $40M in 'at-the-market' common stock »

The shares will be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$362.89

-4.08 (-1.11%)

, ALK

Alaska Air

$70.87

-1.015 (-1.41%)

18:18
11/12/19
11/12
18:18
11/12/19
18:18
Periodicals
U.S. carriers willing to take 737 jets before training clearance, Reuters says »

Certain U.S. airline…

BA

Boeing

$362.89

-4.08 (-1.11%)

ALK

Alaska Air

$70.87

-1.015 (-1.41%)

LUV

Southwest

$57.87

-0.4 (-0.69%)

DAL

Delta Air Lines

$57.23

(0.00%)

JBLU

JetBlue

$19.31

-0.44 (-2.23%)

UAL

United Airlines

$92.73

-0.77 (-0.82%)

SAVE

Spirit Airlines

$37.86

-0.9 (-2.32%)

AAL

American Airlines

$29.51

-1.08 (-3.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 12

    Nov

  • 13

    Nov

  • 13

    Nov

  • 14

    Nov

  • 14

    Nov

  • 12

    Dec

  • 23

    Jan

PBR

Petrobras

$15.65

-0.146 (-0.92%)

18:15
11/12/19
11/12
18:15
11/12/19
18:15
Hot Stocks
Petrobras discloses teaser for sale of assets in Uruguay »

Brazil's Petrobras…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YY

YY

$65.12

-0.28 (-0.43%)

18:05
11/12/19
11/12
18:05
11/12/19
18:05
Hot Stocks
YY reports Q3 global average mobile MAUs 470.1M from 433.5M in Q2 »

Q3 Average mobile MAUs of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

HUYA

Huya

$24.28

-1.05 (-4.15%)

18:04
11/12/19
11/12
18:04
11/12/19
18:04
Hot Stocks
Huya sees Q4 revenue up 55.5%-60.8% YoY »

Sees Q4 total net…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 09

    Dec

YY

YY

$65.12

-0.28 (-0.43%)

18:03
11/12/19
11/12
18:03
11/12/19
18:03
Earnings
Breaking Earnings news story on YY »

YY sees Q4 revenue up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

HUYA

Huya

$24.28

-1.05 (-4.15%)

18:03
11/12/19
11/12
18:03
11/12/19
18:03
Earnings
Huya reports Q3 EPS 7c, consensus 11c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 09

    Dec

YY

YY

$65.12

-0.28 (-0.43%)

18:01
11/12/19
11/12
18:01
11/12/19
18:01
Earnings
YY reports Q3 adjusted EPS 90c, consensus 80c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

LAZ

Lazard

$38.51

-0.03 (-0.08%)

18:00
11/12/19
11/12
18:00
11/12/19
18:00
Hot Stocks
Lazard CAO sells 40,000 class A common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$362.89

-4.08 (-1.11%)

17:53
11/12/19
11/12
17:53
11/12/19
17:53
Periodicals
Boeing moves pilot to new job following leaked messages, Reuters says »

One of two Boeing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

AVYA

Avaya

$12.53

0.08 (0.64%)

, RNG

RingCentral

$172.89

2.57 (1.51%)

17:45
11/12/19
11/12
17:45
11/12/19
17:45
Syndicate
Avaya files to sell 1.75M shares of RingCentral Class A common stock »

Avaya Holdings (AVYA)…

AVYA

Avaya

$12.53

0.08 (0.64%)

RNG

RingCentral

$172.89

2.57 (1.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 13

    Nov

  • 13

    Nov

  • 20

    Nov

  • 09

    Dec

17:45
11/12/19
11/12
17:45
11/12/19
17:45
General news
Breaking General news story  »

Minneapolis Federal…

NVTR

Nuvectra

$1.41

0.085 (6.44%)

17:37
11/12/19
11/12
17:37
11/12/19
17:37
Hot Stocks
Nuvectra to file voluntary petition for reorganization under Chapter 11 »

Nuvectra announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XELB

Xcel Brands

$1.60

(0.00%)

17:34
11/12/19
11/12
17:34
11/12/19
17:34
Hot Stocks
Xcel Brands, Hilco Global acquire intellectual property of Longaberger »

Xcel Brands and Hilco…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

PSNL

Personalis

$10.17

-0.55 (-5.13%)

17:32
11/12/19
11/12
17:32
11/12/19
17:32
Hot Stocks
Personalis expands oncology portfolio, launching cancer genome sequence service »

Personalis announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 19

    Nov

  • 20

    Nov

KTB

Kontoor Brands

$36.07

0.06 (0.17%)

17:28
11/12/19
11/12
17:28
11/12/19
17:28
Initiation
Kontoor Brands initiated  »

Kontoor Brands initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HBI

Hanesbrands

$15.63

-0.355 (-2.22%)

17:25
11/12/19
11/12
17:25
11/12/19
17:25
Initiation
Hanesbrands initiated  »

Hanesbrands initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRQ

Turquoise Hill

$0.47

0.0049 (1.06%)

17:24
11/12/19
11/12
17:24
11/12/19
17:24
Earnings
Turquoise Hill reports Q3 EPS 4c, consensus 0c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

GPS

Gap

$17.16

0.06 (0.35%)

17:23
11/12/19
11/12
17:23
11/12/19
17:23
Initiation
Gap initiated  »

Gap initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

ADP

ADP

$166.40

3.04 (1.86%)

17:22
11/12/19
11/12
17:22
11/12/19
17:22
Hot Stocks
ADP announces $5B share repurchase program »

The board of directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

KNSL

Kinsale Capital Group

$88.98

1.78 (2.04%)

, DF

Dean Foods

$0.79

(0.00%)

17:18
11/12/19
11/12
17:18
11/12/19
17:18
Hot Stocks
Kinsale Capital Group to replace Dean Foods in S&P 600 at open on 11/18 »

Dean Foods announced that…

KNSL

Kinsale Capital Group

$88.98

1.78 (2.04%)

DF

Dean Foods

$0.79

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

  • 04

    Dec

GIII

G-III Apparel

$28.51

-0.35 (-1.21%)

17:17
11/12/19
11/12
17:17
11/12/19
17:17
Initiation
G-III Apparel initiated  »

G-III Apparel initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SGEN

Seattle Genetics

$110.62

2.44 (2.26%)

17:17
11/12/19
11/12
17:17
11/12/19
17:17
Hot Stocks
Seattle Genetics submits arbitration demand against Daiichi Sankyo »

Seattle Genetics, Inc.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 15

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.